Page last updated: 2024-09-03

perospirone and Basal Ganglia Diseases

perospirone has been researched along with Basal Ganglia Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kono, B; Kurosawa, H; Takei, D; Yomiya, K1
Fabbri, C; Kato, M; Kinoshita, T; Koshikawa, Y; Nonen, S; Okugawa, G; Sakai, S; Serretti, A; Sunada, N; Takekita, Y; Wakeno, M1
Kato, M; Kinoshita, T; Kishimoto, T; Koh, J; Matsumoto, N; Morikawa, M; Okugawa, G; Shinosaki, K; Wakeno, M; Yoneda, H1
Koyama, T; Nakagawa, S1
Ohno, Y1

Reviews

2 review(s) available for perospirone and Basal Ganglia Diseases

ArticleYear
[Extrapyramidal syndrome].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dystonia; Humans; Indoles; Isoindoles; Parkinsonian Disorders; Quetiapine Fumarate; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Syndrome; Thiazoles

2003
[Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2000, Volume: 116, Issue:4

    Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Humans; Indoles; Isoindoles; Schizophrenia; Serotonin Antagonists; Thiazoles

2000

Trials

2 trial(s) available for perospirone and Basal Ganglia Diseases

ArticleYear
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
    European archives of psychiatry and clinical neuroscience, 2015, Volume: 265, Issue:7

    Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Female; Humans; Isoindoles; Male; Middle Aged; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult

2015
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles

2009

Other Studies

1 other study(ies) available for perospirone and Basal Ganglia Diseases

ArticleYear
[A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:8

    Topics: Antiemetics; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Nausea; Neoplasms; Opioid-Related Disorders; Palliative Care; Prochlorperazine; Retrospective Studies; Thiazoles; Vomiting

2013